4//SEC Filing
WILSON GAYLE E 4
Accession 0001127602-20-004969
CIK 0000882095other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 7:02 PM ET
Size
11.2 KB
Accession
0001127602-20-004969
Insider Transaction Report
Form 4
WILSON GAYLE E
Director
Transactions
- Exercise/Conversion
Common Stock
2020-02-10$19.63/sh+21,720$426,364→ 148,502 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2020-02-10−21,720→ 0 totalExercise: $19.63Exp: 2020-05-11→ Common Stock (21,720 underlying) - Sale
Common Stock
2020-02-10$67.72/sh−21,720$1,470,878→ 126,782 total
Footnotes (2)
- [F1]Sale prices reported for the transactions reported here range from $67.71 to $67.76. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- [F2]The options vesed quarterly over the first year of service and were fully vested on May 11, 2011.
Issuer
GILEAD SCIENCES INC
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001198227
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 7:02 PM ET
- Size
- 11.2 KB